I agree that this site is using cookies. You can find further informations here.
X
Kantor, Daniel
93  results:
OpenAccess-fulltext X
Search for persons X
?
1

Digital Scientific Platform for Independent Content in Neur..:

Kantor, Daniel ; Farlow, Martin ; Ludolph, Albert...
1929-073X.  , 2022
Link: http://hdl.handle.net/10..
 
?
2

Digital Neurology Platform: Developing and implementing a r..:

Kantor, Daniel ; Farlow, Martin ; Deschet, Karine...
info:eu-repo/semantics/altIdentifier/issn/1929-073X.  , 2022
Link: https://pub.dzne.de/reco..
 
?
3

Confirmed 6-Month Disability Improvement and Worsening Corr..:

Hunter, Samuel F ; Aburashed, Rany A ; Alroughani, Raed...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571457/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
4

Confirmed 6-Month Disability Improvement and Worsening Corr..:

Hunter, Samuel F ; Aburashed, Rany A ; Alroughani, Raed...
https://boris.unibe.ch/159337/.  , 2021
Link: https://boris.unibe.ch/1..
 
?
5

Confirmed 6-Month Disability Improvement and Worsening Corr..:

Hunter, Samuel F ; Aburashed, Rany A ; Alroughani, Raed...
2193-8253.  , 2021
Link: http://hdl.handle.net/10..
 
?
6

Development of Glatopa® (Glatiramer Acetate): The First FDA..:

Bell, Christine ; Anderson, James ; Ganguly, Tanmoy...
qt8k30d36z.  , 2018
Link: https://escholarship.org..
 
?
7

Effectiveness of alternative dose fingolimod for multiple s..:

Longbrake, Erin E ; Kantor, Daniel ; Pawate, Siddharama...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914753/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

Equivalent Gene Expression Profiles between Glatopa™ and Co..:

D'Alessandro, Josephine S ; Duffner, Jay ; Pradines, Joel...
qt34x9f0tb.  , 2015
Link: https://escholarship.org..
 
?
9

Impact of a switch to fingolimod versus staying on glatiram..:

Calkwood, Jonathan ; Cree, Bruce ; Crayton, Heidi...
qt5gh362jf.  , 2014
Link: https://escholarship.org..
 
?
10

Minorías sexuales: sobre el paradigma de la Tolerancia y el..:

Kantor, Daniel
Política y cultura n.35 2011.  , 2011
Link: http://www.scielo.org.mx..
 
?
11

Safety and efficacy of dual-lead thalamic deep brain stimul..:

Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, FL, USA ( host institution ) ; Oliveria, Seth F ( UF author ) ; Rodriguez, Ramon L ( UF author )...
The Lancet Neurology.  , 2017
Link: https://doi.org/10.1016/..
 
?
12

Cost Per Relapse Avoided for Ozanimod Versus Other Selected..:

Daniel Kantor ; Timothy Pham ; Oscar Patterson-Lomba...
https://doi.org/10.1007/s40120-023-00463-y.  , 2023
Link: https://doi.org/10.1007/..
 
?
13

Digital Scientific Platform for Independent Content in Neur..:

Daniel Kantor ; Martin Farlow ; Albert Ludolph...
https://www.i-jmr.org/2022/1/e35698.  , 2022
Link: https://doi.org/10.2196/..
 
?
14

Two Sides to Every Story: Perspectives from Four Patients a..:

Jeri Burtchell ; Kristen Fetty ; Katelyn Miller..
http://link.springer.com/article/10.1007/s40120-019-0141-4.  , 2019
Link: https://doi.org/10.1007/..
 
?
15

Equivalent Gene Expression Profiles between Glatopa™ and Co..:

Josephine S D'Alessandro ; Jay Duffner ; Joel Pradines...
http://europepmc.org/articles/PMC4608686?pdf=render.  , 2015
Link: https://doi.org/10.1371/..
 
1-15